Global disputes and investigations firm Kobre & Kim announces today that it has strengthened its Government Enforcement & Investigations team with the addition of Jason A. Masimore in London.
As a former prosecutor for the US Department of Justice (DOJ), Mr. Masimore will focus his practice on advising corporations and individual clients in Europe, the Middle East, and Africa facing allegations of corruption and bribery; securities fraud and tax and accounting fraud; market manipulation; and violations of US sanctions, among other violations.
When asked about joining the firm, Mr. Masimore said, “I am delighted to be joining Kobre & Kim in London. The firm has built an impressive team that has an unparalleled reputation. I am excited for the opportunity to help enhance the firm’s abilities to advise international clients facing investigations and cases from US regulators.”
Mr. Masimore brings extensive experience investigating criminal matters to Kobre & Kim’s London office. With his addition, a total of five former DOJ lawyers will be based at that location. Among these are Lara Levinson and Roger Burlingame; they and Mr. Masimore are permanently based in London. Other former DOJ lawyers on the team include Robert Henoch, who splits time between Tel Aviv and London, and the firm’s co-founder, Michael Kim, who also practices part of the time from the London office.
Full Content: PR News Wire
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas